Cross-Modal Interaction-Aware Progressive Fusion Network for Drug–Target Interaction Prediction
Journal of Chemical Information and Modeling · 13.10.2025 · 65 (19) · 10713-10726
DOI: 10.1021/acs.jcim.5c01429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 19.09.2025. Verfasst von Zhichong Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan 430065, China. Hauptthemen laut MEDLINE: Deep Learning, Drug Discovery, Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan 430065, China.
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
- Hubei Province Key Laboratory of Intelligent Information Processing and Real-time Industrial System, Huangjiahu West Road 2#, Wuhan 430065, China.
ORCID-Profile: Zhichong Cao
Zitieren
APA
Cao, Z., Xie, J., Xu, J., & Li, B. (2025). Cross-Modal Interaction-Aware Progressive Fusion Network for Drug–Target Interaction Prediction. Journal of Chemical Information and Modeling, 65(19), 10713-10726. https://doi.org/10.1021/acs.jcim.5c01429
Vancouver
Cao Z, Xie J, Xu J, Li B. Cross-Modal Interaction-Aware Progressive Fusion Network for Drug–Target Interaction Prediction. Journal of Chemical Information and Modeling. 2025;65(19):10713-10726. doi:10.1021/acs.jcim.5c01429
BibTeX
@article{Cao2025,
author = {Cao, Zhichong and Xie, Jing and Xu, Junlin and Li, Bo},
title = {Cross-Modal Interaction-Aware Progressive Fusion Network for Drug–Target Interaction Prediction},
journal = {Journal of Chemical Information and Modeling},
year = {2025},
volume = {65},
number = {19},
pages = {10713--10726},
doi = {10.1021/acs.jcim.5c01429}
}
EUVIMED